Skip to main content

A role model for change

19th March 2021

Submitted by:

Andrew Warmington

Harry Swan, CEO of Thomas Swan, describes the company’s approach to navigating the new post-Brexit rules and offers advice to other firms

Thomas Swan is an independent, family-run chemicals manufacturer that is based in County Durham, UK. I am the great-grandson of the founder and became CEO in 2006. The company dates back to 1926, so you might expect it to be experienced in handling change. Adapting to the UK’s new free trade deal with the EU is another challenge we have met head-on and we are confident of competing successfully in a global market.

We started early. In fact, as far back as October 2018, we took the decision to survey all our suppliers, both EU and non-EU. We did this to inform them of the potential new UK registration requirements when the UK left the EU and to find out whether they intended to register the chemicals they supplied to us, so that they could continue to supply us with them in future.

At the time, perhaps unsurprisingly, some of the suppliers were not aware of the new requirements and some were unable or unwilling to make the commitments necessary. We therefore budgeted for registering the products ourselves as a precaution, in case we needed to ‘grandfather’ them into UK REACH.

We decided to repeat our supplier survey in 2020, and the answers were much more reassuring. All of our main suppliers were now willing to provide assurances about their intentions to do what was necessary to maintain supplies.

With this clearer path ahead, the company set up conditional agreements with consultants willing to act as representatives in the EU for REACH and for Biocidal Products Regulation registrations. In December 2020, it initiated the transfer of its REACH registrations to an appointed Only Representative (OR) and this process was completed in early 2021.

Thomas Swan has also completed the ‘grandfathering’ process to register all its manufactured and imported products into the UK REACH programme. This facility is open until the end of April.

For a chemical manufacturer, another relevant new trade requirement is in relation to rules of origin. To ensure that our goods complied with these rules, we checked the Trade & Co-operation Agreement (TCA) for the rules of origin requirements and the tariff codes of chemicals for which we claim preference, to make sure they were still correct and that preference still applied.

We also checked the origin of goods purchased from distributors and checked that agreements were in place with other countries. We included the standard format from the TCA annexes for rules of origin information on our invoice documentation.

In addition, we checked our EU employee status and found that one employee did not meet the requirements, so we ensured that this person will be able to achieve them before the June 2021 deadline. We are also applying to be a sponsor in order to allow us to employ EU nationals more easily and quickly if needed in the future.

Sources of information

I believe that the initial disruption will settle down and the business community will get used to the new landscape. I advise other businesses not to panic, we will all get used to the new rules in time. There are some very useful sources of information, including the Health & Safety Executive (HSE) website, for advice on chemicals. Your trade association will also be very helpful.

We used the www.gov.uk/transition website and we also read the relevant parts of the TCA and put them in place where required. We used a freight forwarder for our exports and applied for an Authorised Economic Operator (AEO) status so as to help us avoid any potential customs delays due to cross-border checks. The best place for businesses to get support is www.gov.uk/transition. Other key pieces of advice would be:

* Speak with your lawyer and accountant for more information, or answer questions using the checker tool to generate information tailored to your business and to sign up for email updates

* New on-demand videos are available on the website to help businesses adapt to the new rules. These are searchable by sector and businesses can find out more about 18 topics that may affect them

* For any further queries please contact the business support helpline in the relevant region: England - 0800 998 1098; Business Support Scotland - 0300 303 0660; Business Wales Helpline: 0300 060 300; Invest Northern Ireland helpline - 0800 181 4422

Additional information

To make sure you are fully prepared for the UK’s new free trading relationship with the EU, follow these top five actions, all via www.gov.uk/transition:

1. Find out how you can continue to trade with the EU by following new rules for importing and exporting, including changes to customs processes and licensing. Before you attempt to move your goods, you will need to get ready to make customs declarations – these are now needed for all exports from the UK and if you are importing controlled goods. If you import goods that are not controlled, you may be able to delay making your declarations for up to six months

2. Use official guidance to understand trading arrangements with non-EU countries and check if the UK has negotiated a trade agreement with the country you will be trading with

3. If you move goods into, out of, or through Northern Ireland, make sure you check the latest Northern Ireland Protocol guidance for the specific rules on trading between the rest of the UK, Northern Ireland and the EU (in addition to global trade changes)

4. Familiarise yourself with the UK’s new trade remedies process: Businesses can submit applications via the UK’s new independent trade remedies system if they believe they are being injured by the effects of unfair trade practices or surges in imports

5. Check that your goods comply with rules of origin and that you have the required evidence to trade tariff-free with the EU: Businesses need to take action to access zero tariffs in the TCA. They must check that their goods comply with rules of origin requirements, make a declaration and ensure they have the correct evidence if they wish to claim preferential tariff rates when trading with the EU

Contact:

Steven Warren

Head of PR & Partnerships Communications Directorate

Department for Business, Energy & Industrial Strategy (BEIS)

+44 20 7215 3302

[email protected]

www.gov.uk/beis

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington